Osmind
banner
osmind.bsky.social
Osmind
@osmind.bsky.social
The premier technology platform for breakthrough mental health treatment and research.

Learn more at Osmind.org
Psychiatry can be isolating.

Even when you're leading a multi-site practice. Martha B. Koo, M.D., is Chief Medical Officer of Your Behavioral Health, overseeing multiple clinics across Southern California.
November 21, 2025 at 10:39 PM
You hit 70% capacity and stay there. Wait times in your market are 3-6 months.

We asked psychiatrists and PMHNPs across the country what's blocking their schedules.

The bottleneck is how referrals flow, how you're positioned online, and whether you've built systems to handle growth.
November 19, 2025 at 9:23 PM
That's a wrap on BHT2025! 🌊

Osmind was proud to sponsor three days in San Diego with innovators, clinicians, and advocates working to advance behavioral health through technology.
November 14, 2025 at 10:17 PM
This Veterans Day, we honor those who serve and those who care for them.

At Osmind, we're privileged to support clinicians and researchers working to advance PTSD treatment, from ketamine therapy to new interventional approaches.
November 11, 2025 at 11:10 PM
You never know which conversation will spark a wave of transformation in behavioral health care.
November 6, 2025 at 9:43 PM
Most psychiatric treatments lose effectiveness over time. Vagal nerve stimulation does the opposite.

Lucian Manu, M.D. has helped over 20 patients access VNS at Stony Brook University, many who'd exhausted every other option.

Get the full guide to VNS here:

www.osmind.org/blog/vagal-n...
Vagal Nerve Stimulation (VNS) for Depression: The Treatment That Gets Better Over Time | Osmind
Vagal nerve stimulation (VNS) for depression improves progressively over 12-24 months with remarkably low relapse rates. Learn patient selection criteria, Medicare RECOVER trial access, insurance appe...
www.osmind.org
November 5, 2025 at 3:30 PM
Solo practice means you're good at what you do. It also means you're isolated.

Dr. Jacob Behrens, MD runs Envision ADHD in Wisconsin. He joined The Psychiatry Collective to stay current on emerging treatments—but discovered something more valuable than research updates.
October 30, 2025 at 10:22 PM
Food fell out of the refrigerator. For most people, mildly annoying. For one patient with depression, it used to trigger hours of rage and dysregulation.

After TMS treatment, it happened again. But this time, he picked up the food, put it back, moved on. His wife stood there stunned.
October 28, 2025 at 9:32 PM
"This TMS chair is not Santa's sleigh; it doesn't run on belief."

For patients already carrying the weight of their illness, removing the burden of belief can be transformative.

Listen to the full conversation by searching "Psychiatry Tomorrow" on your favorite podcast platform!
October 15, 2025 at 9:01 PM
Mental healthcare takes a village. We need each other.

We're grateful for the researchers asking hard questions, the clinicians showing up every day, and the pioneers trying new approaches when the old ones aren't enough. You're making a difference.
October 10, 2025 at 8:39 PM
"The cat's out of the bag. I don't see a world in future psychiatry that's just medicine and therapy."

Martha B. Koo, M.D. doesn't mince words about where psychiatry is headed.
October 10, 2025 at 12:26 AM
We're honored that Osmind has been selected from thousands of companies globally as a finalist for:

The Digital Health Hub Foundation - Digital Health Awards
in the Best in Class track - Mental and Behavioral Health category!
October 6, 2025 at 5:14 PM
Most psychiatry practices lose revenue to billing inefficiencies, but don't realize it until cash flow becomes a crisis. Here's your 101 guide to Revenue Cycle Management (no MBA required).
October 1, 2025 at 10:31 PM
"I'm good, but I'm not my true full self."

Dr. Martha B. Koo, M.D., LFAPA, FASAM, FCTMSS heard this from her own therapy patients after placing a simple TMS brochure in her waiting room.

These were patients she considered stable on medication and therapy.
September 30, 2025 at 4:19 PM
Ketamine + TMS + Spravato: What's working in real practice?

If you're offering ketamine as a treatment, you've probably wondered about combining it with TMS or Spravato. The data is promising, but practical questions are endless: patient selection, sequencing, what actually works.
September 24, 2025 at 9:02 PM
Psych Congress 2025 Recap: Psilocybin Real-World Evidence and Digital Psychiatry

Just wrapped four days in San Diego for Psych Congress. Wonderful to connect and share new research.

Some highlights:
September 23, 2025 at 5:07 PM
What a nice surprise this week to have TIME recognize Osmind as one of the World's Top Health Tech Companies of 2025!
September 19, 2025 at 7:15 PM
We're proud to announce that Osmind has been selected from thousands of companies globally as a quarterfinalist for The Digital Health Hub Foundation - Digital Health Awards in the Best in Class track - Mental and Behavioral Health category!
September 18, 2025 at 7:40 PM
Since 2020, we've been on a mission to transform psychiatry from guesswork to precision medicine.

Our published real-world research validates what ketamine clinicians see daily—ketamine treatments change lives.
September 15, 2025 at 5:36 PM
Here's what you missed the last two weeks in the Osmind Psychiatry Collective:

🚀 Accelerated TMS Protocols & Device Selection Strategies - live event recap**: Members dove deep into the affordability of new TMS devices and how accelerated protocols are changing patient outcomes.
September 8, 2025 at 7:18 PM
Reposted by Osmind
As digital tools and AI become integral to psychiatry, we may see enhanced accessibility and personalized treatments, transforming mental health care. Let's embrace this future! #futurism
Explore:
•Essential digital tools for psychiatry
•Overcoming barriers to tech adoption
•The future of AI in mental health treatment

📅 Wednesday, September 17, 2025
⏰ 9:00 AM - 12:00 PM
📍 Psych Congress in San Diego: Technology Preconference
September 5, 2025 at 2:01 AM
Psych Congress role call!

How do you identify which patients with TRD are eligible for interventional treatments? Attend the preconference, "Simplifying Digital Psychiatry—Tech for the Everyday Clinician."
September 4, 2025 at 7:20 PM
We're proud to sponsor ASKP3 Mastering Essentials—an event that embodies our shared mission of advancing ketamine treatment through education and community.
September 3, 2025 at 6:07 PM
78% of psychiatrists inside the Psychiatry Collective are already testing or using AI scribes.

This guide cuts through the hype to answer the questions that actually matter:
AI Scribes 101: A Psychiatrist's Quick Start Guide | Osmind
Cut through the AI scribe hype with this psychiatrist's practical guide. Learn what AI scribes actually do, how to address patient privacy concerns, and which questions to ask vendors before you buy.
www.osmind.org
August 28, 2025 at 7:30 PM
Live Event: AI in Psychiatry | Community Discussion

Join us for an unfiltered, community conversation about AI's evolving role in psychiatric practice, inspired by the buzzing community post "Maybe our new AI Overlords will Put Good Coffee In the Lounge?"
August 19, 2025 at 7:22 PM